PriceTargets.com logo

NASDAQ:AQB - AquaBounty Technologies Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $5.83
  • Forecasted Upside: -2.29 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$5.97 As of 03/4/2021 03:20 PM ET
▼ -0.54 (-8.29%)
1 month | 3 months | 12 months
Get New AquaBounty Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AQB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AQB

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$5.83
▼ -2.29% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for AquaBounty Technologies in the last 3 months. The average price target is $5.83, with a high forecast of $9.00 and a low forecast of $3.50. The average price target represents a -2.29% upside from the last price of $5.97.
Buy
The current consensus among 3 polled investment analysts is to buy stock in AquaBounty Technologies. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/11/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/10/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/2/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/4/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/11/2020Lake Street CapitalBoost Price Target$5.00 ➝ $9.00Low
i
11/4/2020National SecuritiesReiterated RatingBuy$5.00Low
i
8/24/2020National SecuritiesReiterated RatingBuy$5.00High
i
Rating by Ben Klieve at National Securities
6/12/2020HC WainwrightReiterated RatingBuy$3.50High
i
Rating by Kevin Dede at HC Wainwright
5/22/2020HC WainwrightReiterated RatingBuy$3.50N/A
i
Rating by Kevin Dede at HC Wainwright
5/21/2020National SecuritiesReiterated RatingBuy$5.00High
i
Rating by Ben Klieve at National Securities
5/7/2020HC WainwrightReiterated RatingBuy$3.50High
i
5/6/2020National SecuritiesReiterated RatingBuy$5.00High
i
3/26/2020HC WainwrightLower Price TargetBuy$3.75 ➝ $3.50Low
i
3/12/2020Lake Street CapitalInitiated CoverageBuy$5.00High
i
3/11/2020National SecuritiesReiterated RatingBuy$5.00High
i
1/13/2020National SecuritiesUpgradeNeutral ➝ BuyMedium
i
9/20/2019National SecuritiesDowngradeBuy ➝ NeutralHigh
i
8/7/2019National SecuritiesReiterated RatingBuy ➝ Buy$5.00 ➝ $5.00Low
i
7/11/2019HC WainwrightSet Price TargetBuy$4.00High
i
Rating by Kevin Dede at HC Wainwright
6/10/2019National SecuritiesReiterated RatingBuy ➝ Buy$5.00 ➝ $5.00Low
i
5/10/2019HC WainwrightReiterated RatingBuy$3.75High
i
Rating by Kevin Dede at HC Wainwright
5/6/2019National SecuritiesReiterated RatingBuy ➝ Buy$5.00 ➝ $5.00Low
i
3/28/2019HC WainwrightSet Price TargetBuy$4.00Medium
i
Rating by Kevin Dede at HC Wainwright
3/20/2019National SecuritiesLower Price TargetBuy ➝ Buy$6.50 ➝ $5.50Low
i
3/6/2019National SecuritiesInitiated CoverageBuy ➝ Buy$6.50 ➝ $6.50High
i
12/27/2018HC WainwrightSet Price TargetBuy$4.00High
i
Rating by Kevin Dede at HC Wainwright
11/28/2018HC WainwrightSet Price TargetBuy$4.00Low
i
Rating by Kevin Dede at HC Wainwright
11/16/2018HC WainwrightSet Price TargetBuy$4.00Medium
i
Rating by Kevin Dede at HC Wainwright
9/17/2018HC WainwrightSet Price TargetBuy$4.00High
i
Rating by Kevin Dede at HC Wainwright
8/8/2018HC WainwrightReiterated RatingBuy$4.00High
i
Rating by K. Dede at HC Wainwright
6/28/2018HC WainwrightInitiated CoverageBuy$3.75Low
i
Rating by K. Dede at HC Wainwright
(Data available from 3/4/2016 forward)
AquaBounty Technologies logo
AquaBounty Technologies, Inc. develops and markets products to enhance productivity in land-based aquaculture. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was founded in 1991 and is headquartered in Maynard, Massachusetts.
Read More

Today's Range

Now: $5.97
$5.78
$6.74

50 Day Range

MA: $9.61
$7.09
$12.20

52 Week Range

Now: $5.97
$1.59
$13.32

Volume

201,610 shs

Average Volume

3,727,749 shs

Market Capitalization

$420.57 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.27

Frequently Asked Questions

What sell-side analysts currently cover shares of AquaBounty Technologies?

The following sell-side analysts have issued stock ratings on AquaBounty Technologies in the last year: HC Wainwright, Lake Street Capital, National Securities, and Zacks Investment Research.
View the latest analyst ratings for AQB.

What is the current price target for AquaBounty Technologies?

3 Wall Street analysts have set twelve-month price targets for AquaBounty Technologies in the last year. Their average twelve-month price target is $5.83, suggesting a possible downside of 2.3%. Lake Street Capital has the highest price target set, predicting AQB will reach $9.00 in the next twelve months. HC Wainwright has the lowest price target set, forecasting a price of $3.50 for AquaBounty Technologies in the next year.
View the latest price targets for AQB.

What is the current consensus analyst rating for AquaBounty Technologies?

AquaBounty Technologies currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AQB will outperform the market and that investors should add to their positions of AquaBounty Technologies.
View the latest ratings for AQB.

What other companies compete with AquaBounty Technologies?

Other companies that are similar to AquaBounty Technologies include Aurinia Pharmaceuticals, Pandion Therapeutics, ModivCare, Madrigal Pharmaceuticals, Inovio Pharmaceuticals, Zentalis Pharmaceuticals, ADC Therapeutics, Scholar Rock, C4 Therapeutics, Shattuck Labs, Heska, Silverback Therapeutics, ImmunoGen, Organogenesis and Cardiovascular Systems.

How do I contact AquaBounty Technologies' investor relations team?

AquaBounty Technologies' physical mailing address is 2 MILL & MAIN PLACE SUITE 395, MAYNARD MA, 01754. The company's listed phone number is 978-648-6000 and its investor relations email address is [email protected] The official website for AquaBounty Technologies is www.aquabounty.com.